Type in product code or name:
|EB06456||Goat Anti-PRL1 / PTP4A1 Antibody||Pep-ELISA, WB, IF||100µg specific antibody in 200µl||Human, Mouse||$392.00|
Ordering Information for
Order direct from Everest
$49.00: Overnight shipping (not applicable to SB-shifix) to United States of America
Sent via overnight courier arrives approximately next day to mainland USA. Please note that your order will be shipped by our US partner Abcore LLC.
Now shipping direct to US customers! 99% of products are held in stock for immediate shipment, see individual product pages for availability.
Please order through the US Dollar shopping cart (links on each product page) or we accept orders by email ([email protected]), fax (888-841-9041), phone (888-320-4628). Please include the following information with your order:
In stock orders received by 13.30 PST on Monday through Thursday are shipped the same day.
Orders are shipped by our US logistics partner Abcore LLC.
Peptide with sequence CFKDSNGHRNN, from the C Terminus of the protein sequence according to NP_003454.1.
Please note the peptide is available for sale.
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing.
Immunofluorescence: Strong expression of the protein seen in HeLa and NIH3T3 cells. Recommended concentration: 10µg/ml.
Additional validation: This antibody has been successfully used in the following paper: Achiwa H et al. (2007) PMID: 17234774.
This antibody has been successfully used in WB on Mouse:
Byungtae Hwang, Min-Gi Kwon, Min Ji Cho, Nam-Kyung Lee, Jangwook Lee, Jeong Woong Lee, Kyoung-Jin Oh, Kwang-Hee Bae, Jung Hwan Hwang, Jeong-Ki Min, Jong-Gil Park
Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH/FGF21 axis.
Theranostics. 2023 Jan 22;13(3):1076-1090.
This antibody has been successfully used in WB on Human:
Min SH, Kim DM, Heo YS, Kim YI, Kim HM, Kim J, Han YM, Kim IC, Yoo OJ.
New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53.
Oncogene. 2009 Jan 29;28(4):545-54.
This antibody has been successfully used in the following paper:
Achiwa H, Lazo JS.
PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
Cancer Res. 2007 Jan 15;67(2):643-50.